Oral aniracetam treatment in C57BL/6J mice without pre-existing cognitive dysfunction reveals no changes in learning, memory, anxiety or stereotypy

Background: The piracetam analog, aniracetam, has recently received attention for its cognition enhancing potential, with minimal reported side effects.  Previous studies report the drug to be effective in both human and non-human models with pre-existing cognitive dysfunction, but few studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Reynolds, Conner D., Jefferson, Taylor S., Volquardsen, Meagan, Pandian, Ashvini, Smith, Gregory D., Holley, Andrew J., Lugo, Joaquin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998011/
https://www.ncbi.nlm.nih.gov/pubmed/29946420
http://dx.doi.org/10.12688/f1000research.11023.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998011/
https://www.ncbi.nlm.nih.gov/pubmed/29946420
http://dx.doi.org/10.12688/f1000research.11023.3

Ejemplares similares